LAUREN FAULKNER: Open Payments
NPI 1710259049 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 14 payments from 9 companies in 2025. Trend: 2023 $107 · 2024 $404 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| ABBVIE INC. | 2 | $39 |
| Philips North America LLC | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, VRAYLAR, ECC Solutions, TRELEGY ELLIPTA, VIVITROL, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
